Transforming Cancer Care Through Technology: A Comprehensive Outlook on the Global Oncology Device Market

The global oncology device market represents one of the most dynamic and innovation-driven segments of the healthcare industry. Valued at USD 224.19 billion in 2024, the market is expected to reach USD 257.82 billion by 2025 and expand significantly to USD 518.56 billion by 2030, registering a robust CAGR of 15.0% during the forecast period. This growth is driven by the rising global cancer burden, increasing demand for early diagnosis, and rapid advancements in medical technology. Oncology devices, spanning diagnostic imaging, radiation therapy, interventional tools, and digital platforms, play a critical role across the cancer care continuum. The integration of artificial intelligence, minimally invasive techniques, and personalized medicine is reshaping diagnostics, treatment planning, and patient monitoring. This manuscript presents a comprehensive industry outlook, examining market trends, growth drivers, challenges, segmentation insights, regional dynamics, and competitive strategies shaping the future of oncology devices.